NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BridgeBio Oncology

BridgeBio Oncology

Public
South San Francisco, CaliforniaBiotechwww.bridgebiooncology.com

BridgeBio Oncology is now publicly traded

The data on this page reflects BridgeBio Oncology's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

VC Round

May 2, 2024

Total Funding Raised

$200M

Company Overview

BridgeBio Oncology Therapeutics is a biopharmaceutical company focused on developing small molecule therapeutics to treat genetic diseases and cancers, particularly targeting RAS and PI3K malignancies to enhance treatment outcomes for patients.

Sector

Biotech

AI Layer

Non-AI

Keywords

KRASG12C inhibitorON/OFF inhibitorsmall molecule drugsprecision oncologyRAS targeting medicinescancer drugsPI3Kα inhibitordrug resistancepan-KRAS inhibitorclinical-stage biotechsolid tumorsbiotech SPACnon-small cell lung cancerNSCLCbiotech spinoutcovalent inhibitor

BridgeBio Oncology Comparables

Compare BridgeBio Oncology with similar companies based on industry and business-model similarity.

BridgeBio Oncology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

BridgeBio Oncology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 2, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Eli Wallace

Chief Executive Officer

Executive Team

BridgeBio Oncology Investors

Notable investors and investment history

BridgeBio Oncology investors
InvestorRounds
EcoR1 CapitalVC Round
Enavate SciencesVC Round
Deerfield ManagementVC Round
Omega FundsVC Round
GVVC Round
Aisling CapitalVC Round
CitadelVC Round
View all Investors

BridgeBio Oncology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BridgeBio Oncology Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range95
Year Founded2016
Last FundingMay 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.